Navigation Links
DxInsights Names Ethan K. Knowlden Executive Director
Date:5/15/2013

TUCSON, Ariz. and BOSTON, May 15, 2013 /PRNewswire/ -- DxInsights, a nonprofit, independent organization dedicated to educating industry, academicians, healthcare community and payers on the power of diagnostics, has announced the appointment of Ethan K. Knowlden as Executive Director.  Mr. Knowlden will work directly with DxInsights' Board and Steering Committee and will be responsible for the operations and activities of the association on a day-to-day basis, in addition to maintaining a strategic vision for the organization in order to achieve its stated objectives. 

"We are pleased to have Ethan join our ranks as we accelerate DxInsights' impact in healthcare," said Mara G. Aspinall , President/Chief Executive Officer of Ventana Medical Systems and Founder of DxInsights.  "The combination of his unique skills and experience in both the diagnostics and pharmaceutical industry is invaluable, and his leadership will help us achieve our goal to educate key decision-makers on the impact of diagnostics."

Prior to joining DxInsights, Mr. Knowlden was with Novartis Vaccines and Diagnostics, Inc. for the last 12 years in both Emeryville, CA, and London, U.K., and most recently served as Vice President, Business Development & Licensing, Corporate Counsel for the Diagnostics unit.  He has significant transactional and commercial experience with a wide range of diagnostic technologies, including ELISA, PCR and DNA microarrays, as well as next-generation sequencing.  Mr. Knowlden received his J.D. from the University of Virginia and his B.A. from Wesleyan University.

"Having been involved in diagnostics for over a decade, I know there is a great need to educate those who are impacted by and make decisions about the use of these important tools," said Knowlden.  "I am very excited to work with this extremely impressive organization and its strong leadership to accelerate all healthcare stakeholders' understanding of the value and influence of diagnostics in important healthcare decisions."

According to  DxInsights' most recent white paper, diagnostics offer the critical data a physician needs to design a treatment plan for each patient, providing information for 60 percent of the medical care decisions made today, but accounting for only two percent of the spend. Diagnostics are not well understood or valued by many providers, payers, policymakers or patients.DxInsights is committed to ensuring that this information is understood and embraced by critical decision-makers to improve patient outcomes and reducing costs in healthcare.  As a result, DxInsights' Founder, Kristin Pothier , led a panel on April 22nd at BIO 2013 in Chicago on "Panacea or Pain: Collaboration in Personalized Medicine."  In addition, DxInsights recently hosted the first of its free Essentials of Diagnostics webinar series on "Understanding Reimbursement" on April 29th at 12 noon ET.  For more details, please go to www.dxinsights.net.

About DxInsights
Founded by seasoned executives involved in all facets of diagnostics including development, commercialization, regulatory, reimbursement and communications, DxInsights has gathered the most relevant information in all of the above areas to create a central reference hub for healthcare executives, the medical, regulatory and reimbursement communities as well as patients to easily access information in one place and learn about the critical role of diagnostics in guiding the future of healthcare, including personalized medicine.  DxInsights was founded by Mara Aspinall , President/Chief Executive Officer of Ventana Medical Systems and Kristin Ciriello Pothier , Partner, Health Advances and co-founded by Hathaway Pease Russell Partner, Foley Hoag , and Terri Clevenger , President, Continuum Health Communications.

DxInsights' Web site, www.dxinsights.net, provides information on the diagnostics industry including scientific research, industry reports, legal decisions, mergers & acquisitions, regulatory issues and reimbursement needs. It also provides helpful links to other important resources in the diagnostics world.  DxInsights encourages any and all members of the healthcare community to become a member at no charge.  Funding is through educational grants and sponsorships.

For more information about DxInsights, please visit www.dxinsights.net.Contact:

Terri ClevengerContinuum Health Communications(203) 856-4326tclevenger@continuumhealthcom.com  


'/>"/>
SOURCE DxInsights
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Maxim Healthcare Services Names National Caregiver of the Year Winner
2. Comprehensive Care Corporation Names Colonel Ramon Martinez President of CompCare Pharmacy Solutions, Inc.
3. Care Corporation Names Colonel Ramon Martinez President of CompCare Pharmacy Solutions, Inc.
4. NxStage Names Robert G. Funari Chairman Of The Board
5. Sense4Baby, Inc. Names Dr. Jessica Grossman President and CEO
6. Second ISPE-FDA Event Attracts Top Names, Features Release of Drug Shortage Survey Results
7. Hospira Names Matthew R. Stober Senior Vice President of Operations
8. Covagen Names Elias Papatheodorou Chief Business Officer
9. IDEXX Laboratories Names Jeffrey Fiarman Executive Vice President and General Counsel
10. Collegium Pharmaceutical Names Douglas Carlson to Vice President of Business Development
11. Quest Diagnostics Names Sukumar Nagendran, M.D., Vice President, Medical Affairs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/14/2017)... HACKENSACK, N.J. and PETACH TIKVAH, ... Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult ... for the second quarter ending June 30, 2017. ... advanced stages of preparing for our pivotal Phase 3 ... Chaim Lebovits , President and Chief Executive Officer ...
(Date:8/8/2017)... Second-quarter 2017 revenues of $876 million ... continuing operations Second-quarter 2017 ... million Second-quarter 2017 Sterile ... Second-quarter 2017 adjusted diluted earnings ... to $0.93 Second-quarter 2017 ...
(Date:8/7/2017)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation,s largest independent specialty ... 2017.  All comparisons, unless otherwise noted, are to the quarter ... Second Quarter 2017 Highlights include: ... of 3.5% Total prescriptions dispensed of 220,000, ... versus 7.6% Gross profit per prescription ...
Breaking Medicine Technology:
(Date:8/23/2017)... VA (PRWEB) , ... August 23, 2017 , ... The Stevie® Awards have announced the ... Business Awards , the world’s premier business awards competition. , Nominees in the 2017 IBAs ... determined by a points system based on the total number of awards won in the ...
(Date:8/23/2017)... ... August 23, 2017 , ... Boling ... returned home to Indiana, and is now seeing patients at Boling Vision Center’s ... specializes in the diagnosis and treatment of eye disease, medical retina, high-technology cataract ...
(Date:8/23/2017)... ... August 23, 2017 , ... ... Academy of Orthopaedic Surgeons , points out that therapeutic modalities (physical therapy) is ... injury. According to the report, a wider scope of physical therapy options is ...
(Date:8/22/2017)... ... August 22, 2017 , ... Western ... spoke at a popular international aesthetics conference for medical professionals about the positive ... patients’ health and his growing practice. , Dr. George K. Ibrahim ...
(Date:8/22/2017)... ... ... Glass is new to the Texas market, but is proudly managed by widely recognized All ... models, in Grand Prairie, TX, located in the center of the DFW Metroplex, the fourth ... for the past 40 years with 32 convenient locations in Texas, Nevada and California resulting ...
Breaking Medicine News(10 mins):